Anzeige
Mehr »
Freitag, 12.12.2025 - Börsentäglich über 12.000 News
Schock aus China - Lithium zieht an, Antimon wird politisch: Diese Aktie könnte 2026 durchstarten
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A416MF | ISIN: US09061H4065 | Ticker-Symbol:
NASDAQ
12.12.25 | 19:17
2,540 US-Dollar
-1,93 % -0,050
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMERICA INC Chart 1 Jahr
5-Tage-Chart
BIOMERICA INC 5-Tage-Chart

Aktuelle News zur BIOMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoEgyptian drug authority approves Biomerica's cancer screening portfolio2
DoBiomerica, Inc.: Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio2
25.11.Biomerica, Inc.: Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS2
BIOMERICA Aktie jetzt für 0€ handeln
06.11.Biomerica, Inc.: Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand2
16.10.Biomerica, Inc.: Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S.315- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy...
► Artikel lesen
15.10.Biomerica GAAP EPS of $0.00, revenue of $1.4M1
15.10.Biomerica, Inc.: Biomerica Reports First Quarter Fiscal 2026 Financial Results150Reported Improved Gross Margin from Contribution from Higher-Margin Product MixOperating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company's...
► Artikel lesen
14.10.BIOMERICA INC - 10-Q, Quarterly Report1
08.10.Former LabCorp Diagnostics CEO Gary Huff joins Biomerica board3
08.10.Biomerica, Inc.: Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors3
08.10.BIOMERICA INC - 8-K, Current Report3
26.09.BIOMERICA INC - 10-K/A, Annual Report1
09.09.Biomerica launches AI tool to help IBS patients manage trigger foods1
09.09.Biomerica startet KI-Tool zur Ernährungssteuerung bei Reizdarmsyndrom1
09.09.Biomerica, Inc.: Biomerica Launches AI-Backed inFoods IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes2
03.09.Biomerica Retreats as UAE Okays Kidney Test1
03.09.Biomerica stock rises after UAE health ministry approves kidney test3
03.09.Biomerica: United Arab Emirates Ministry Of Health And Prevention Approves Fortel Kidney Test-
03.09.UAE approves Biomerica's 10-minute home kidney test for diabetic patients1
03.09.Biomerica, Inc.: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Kidney Test for Home Use1
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1